Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Feldman

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Human Gene Therapy Methods|April 21, 2012
A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesShicheng Yang, Neel K Karne, Stephanie L Goff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2018
Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell EngraftmentYasuyuki Arai, Uimook Choi, Cristina I Corsino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer ImmunotherapyXin Yao, Yong-Chen Lu, Linda L Parker, et al.
Cancer Cell|November 11, 2022
Challenges in neoantigen-directed therapeuticsLien Lybaert, Steve Lefever, Bruno Fant, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Human Gene Therapy|July 12, 2012
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for gliomaRichard A Morgan, Laura A Johnson, Jeremy L Davis, et al.
Human Gene Therapy|July 29, 2010
Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cellsSteven A Feldman, Stephanie L Goff, Hui Xu, et al.
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Human Gene Therapy Methods|April 21, 2012
A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesShicheng Yang, Neel K Karne, Stephanie L Goff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2018
Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell EngraftmentYasuyuki Arai, Uimook Choi, Cristina I Corsino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer ImmunotherapyXin Yao, Yong-Chen Lu, Linda L Parker, et al.
Cancer Cell|November 11, 2022
Challenges in neoantigen-directed therapeuticsLien Lybaert, Steve Lefever, Bruno Fant, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Human Gene Therapy|July 12, 2012
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for gliomaRichard A Morgan, Laura A Johnson, Jeremy L Davis, et al.
Human Gene Therapy|July 29, 2010
Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cellsSteven A Feldman, Stephanie L Goff, Hui Xu, et al.
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
Pageof 7